AtriCure, Inc. (ATRC) Posts Q1 Loss of 10c/Share

AtriCure, Inc. (NASDAQ: ATRC) reported Q1 EPS of ($0.10), $0.01 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $19.4 million versus the consensus estimate of $18.62 million.

For earnings history and earnings-related data on AtriCure, Inc. (ATRC) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Lowe's (LOW) PT Lowered to $275 at Guggenheim
• Walmart (WMT) PT Lowered to $130 at Guggenheim
• Bicara Therapeutics (BCAX) Reiterated at Market Outperform by Citizens as Pivotal Trial Advances